Moneycontrol
Get App
SENSEX NIFTY
you are here:

Kilitch Drugs (India) Ltd.

BSE: 524500 | NSE: KILITCH |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE729D01010 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Feb 14, 16:00
120.50 1.80 (1.52%)
Volume
AVERAGE VOLUME
5-Day
2,108
10-Day
4,940
30-Day
2,685
1,901
  • Prev. Close

    118.70

  • Open Price

    121.50

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 14, 15:46
119.80 0.25 (0.21%)
Volume
AVERAGE VOLUME
5-Day
16,274
10-Day
37,287
30-Day
18,677
14,891
  • Prev. Close

    119.55

  • Open Price

    118.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    119.80 (7)

Annual Report

For Year :
2015 2014 2013 2011 2010 2009 2008 2007

Chairman's Speech

Dear Shareholders, On behalf of the Board of Directors, I extend a warm welcome to all of you to the 23rd Annual General Meeting of our company. I am delighted to say that throughout the year our company continued to evolve and expand, still remaining focused on its core strategy of becoming a leading Manufacturer & Exporter of Pharmaceutical products across the globe. While we continue to operate in the same industry, the services we provide, as a result of our merger and acquisition activity, have expanded considerably. To realise better results from a performance-oriented approach, our Company has also increased performance-linked incentives and introduced mentoring programmes for our employees. We are continuously expanding our sales and marketing reach, My primary aim is to reignite growth and to rebuild the high-performance culture of the Company, as well as a value system all stakeholders can be proud of. On the production front, our Thane factory have been augmented and restructured. As we regain momentum, we will continue to deliver value to our customers and stimulating, challenging work to our people, while we create a better working environment, in which our existing and new employees can thrive. I strongly believe that we enjoy a robust foundation that will support growth across all our lines of businesses. We have demonstrated our capabilities in different segments and markets across the globe. I intend to continue to leverage this solid platform to achieve our aspirations and deliver value to our stakeholders. As we step into a new phase of vitality, we continue to rely on this support and confdence. Mukund P. Mehta Managing Director